Literature DB >> 24763846

Subcutaneous abscess due to Pyrenochaeta romeroi in a renal transplant recipient.

Yuen Yue Candice Chan1, Ai Ling Tan, Ban Hock Tan.   

Abstract

An infective aetiology, including fungal infection, should be considered in the differential diagnosis of immunocompromised patients presenting with skin lesions. Dematiaceous fungi are recognised as pathogens in organ transplant recipients. Herein, we describe a rare case of a chronic necrotising granulomatous skin lesion caused by Pyrenochaeta romeroi in a renal transplant recipient, and review the existing literature on the topic. To the best of our knowledge, this is the first report of such a case in Singapore. Recognition of infections caused by dematiaceous fungi is important because some strains are difficult to identify and require special molecular diagnostic techniques. Treatment involves surgical excision and long-term antifungal therapy. Data on the optimal antifungal regimen in such a diagnosis is limited.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24763846      PMCID: PMC4291956          DOI: 10.11622/smedj.2014063

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  8 in total

1.  Subcutaneous phaeohyphomycosis due to Pyrenochaeta romeroi in a patient with leprosy.

Authors:  Céline Girard; Olivier Dereure; Philippe Rispail; Luc Durand; Jean-Jacques Guilhou
Journal:  Acta Derm Venereol       Date:  2004       Impact factor: 4.437

2.  Subcutaneous phaeohyphomycotic cyst caused by Pyrenochaeta romeroi.

Authors:  H Badali; J Chander; N Gulati; A Attri; R Chopra; M J Najafzadeh; S Chhabra; J F G M Meis; G S de Hoog
Journal:  Med Mycol       Date:  2010-08       Impact factor: 4.076

3.  Isolation, identification and susceptibility of Pyrenochaeta romeroi in a case of eumycetoma of the foot in the UK.

Authors:  Dasa Cerar; Yassen M Malallah; Susan J Howard; Paul Bowyer; David W Denning
Journal:  Int J Antimicrob Agents       Date:  2009-09-23       Impact factor: 5.283

4.  Pyrenochaeta romeroi: a causative agent of phaeohyphomycotic cyst.

Authors:  Ziauddin Khan; Suhail Ahmad; Kusum Kapila; Noorni V Ramaswamy; Preetha Alath; Leena Joseph; Rachel Chandy
Journal:  J Med Microbiol       Date:  2011-02-24       Impact factor: 2.472

5.  [Opportunistic fungi as producers of gray colonies and mycetomata].

Authors:  D Borelli
Journal:  Dermatologica       Date:  1979

6.  [Fungal mycetoma with black grains due to Pyrenochaeta romeroi in Cambodia].

Authors:  M André; V Brumpt; P Destombes; G Segretain
Journal:  Bull Soc Pathol Exot Filiales       Date:  1968 Jan-Feb

7.  A nodulo-cystic eumycetoma caused by Pyrenochaeta romeroi in a renal transplant recipient: A case report.

Authors:  Umasankar Mathuram Thiyagarajan; Atul Bagul; Michael L Nicholson
Journal:  J Med Case Rep       Date:  2011-09-14

8.  Itraconazole treatment of phaeohyphomycosis.

Authors:  P K Sharkey; J R Graybill; M G Rinaldi; D A Stevens; R M Tucker; J D Peterie; P D Hoeprich; D L Greer; L Frenkel; G W Counts
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

  8 in total
  3 in total

Review 1.  Subcutaneous Phaeohyphomycosis Caused by Pyrenochaeta romeroi in a Rheumatoid Arthritis Patient: A Case Report with Review of the Literature.

Authors:  Sonam Sharma; Malini R Capoor; Mukul Singh; Deepti Kiran; Ashish Kumar Mandal
Journal:  Mycopathologia       Date:  2016-06-10       Impact factor: 2.574

2.  Subcutaneous Phaeohyphomycosis Cyst Associated with Medicopsis romeroi in an Immunocompromised Host.

Authors:  Alireza Abdolrasouli; Ximena Gonzalo; Anita Jatan; Gordon J McArthur; Nicholas Francis; Berge S Azadian; Andrew M Borman; Elizabeth M Johnson
Journal:  Mycopathologia       Date:  2016-05-18       Impact factor: 2.574

3.  Subcutaneous phaeohyphomycosis from Medicopsis romeroi in a diabetic patient.

Authors:  Pattriya Chanyachailert; Charussri Leeyaphan; Sumanas Bunyaratavej; Piriyaporn Chongtrakool
Journal:  Med Mycol Case Rep       Date:  2019-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.